Microbicide Trials Network

MTN in the News

Voice: When adherence is key

The Herald (Zimbabwe)

March 14, 2013

 

Seven days: 8–14 March 2013

Nature.com

March 14, 2013

 

Women confound HIV researchers

Mail & Guardian (South Africa)

March 8, 2013

 

Human nature sinks HIV prevention trial

Science

March 7, 2013

 

HIV prevention trial fails test

News Day (Zimbabwe)

March 6, 2013

 

Africa: Another blow for microbicide HIV prevention

SciDev.Net

March 6, 2013

 

What’s up with women and HIV-prevention method PrEP?

Daily KOS

March 6, 2013

 

AIDS pills not taken

Daily News (South Africa)

March 5, 2013

 

HIV trial tests fail after participants shun regimen

Daily News (South Africa)

March 5, 2013

 

Trial of HIV prevention tools for women fails due to lack of adherence

POZ

March 5, 2013

 

Women's low adherence to daily-dose products in HIV prevention trial suggest different approach needed, researchers say

Kaiser Daily Global Health Policy Report

March 5, 2013

 

Test of gel, pills to prevent HIV fails in real-life study

NBC News

March 5, 2013

 

African Trial of H.I.V. Drugs Fails

New York Times

March 5, 2013

 

Gilead Drugs to Prevent HIV Spurned by African Women in Study

Bloomberg News

March 5, 2013

 

Pre-exposure HIV Prophylaxis Type Doesn't Matter

Medpage Today

March 5, 2013

 

Mulago HIV drug trial disappoints researchers

New Vision (Uganda)

March 5, 2013

 

Women ‘not keen on HIV prevention methods’

Business Day (South Africa)

March 5, 2013

 

Africa: Big Prevention Blow as Women Reject One-a-Day ARV

AllAfrica.com

March 5, 2013

 

'Daily-dose HIV prevention fails African women'

South African Press Association

March 5, 2013

 

ARV not effective in HIV prevention among unmarried women

Daily Monitor (Uganda)

March 5, 2013

 

HIV/AIDS: Disappointment in HIV prevention trial

IRIN/PlusNews

March 5, 2013 

 

After VOICE trial, question remains: What were women telling researchers?

Science Speaks:  HIV & TB News

March 5, 2013

 

Daily-dose HIV prevention fails for African women: study

AFP

March 5, 2013

 

Daily-dose HIV prevention fails for Africa

AAP (Australian National News Wire)

March 5, 2013

 

Understanding the VOICE Trial Results

Impatient Optimists (Bill & Melinda Gates Foundation)

March 5, 2013

 

Study: Daily ARV recommendation is ineffective among HIV-negative African women

Mail & Guardian (South Africa)

March 4, 2013

 

Big prevention blow as women reject one-a-day ARV

Health-e News Service (South Africa)

March 4, 2013

 

HIV trial yields disappointing results

Voice of America

March 4, 2013 

 

VOICE trial's disappointing result poses big questions for PrEP

Aidsmap.com

March 4, 2013

 

Another trial to help women control HIV infection ends in setback

Citizen News Service

March 4, 2013

 

Patient failures undermine AIDS-prevention plan, study finds

Washington Times

March 4, 2013

 

VOICE: Low adherence to tenofovir among young women

Healio

March 4, 2013